These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
130 related items for PubMed ID: 1694132
1. Down-regulation of CD5 mRNA in B-chronic lymphocytic leukemia cells by differentiation-inducing agents. Gignac SM, Buschle M, Hoffbrand AV, Drexler HG. Eur J Immunol; 1990 May; 20(5):1119-23. PubMed ID: 1694132 [Abstract] [Full Text] [Related]
2. Bryostatin 1-induced hairy cell features on chronic lymphocytic leukemia cells in vitro. al-Katib A, Mohammad RM, Dan M, Hussein ME, Akhtar A, Pettit GR, Sensenbrenner LL. Exp Hematol; 1993 Jan; 21(1):61-5. PubMed ID: 8093352 [Abstract] [Full Text] [Related]
3. Synergistic action of calcium ionophore A23187 and protein kinase C activator bryostatin 1 on human B cell activation and proliferation. Drexler HG, Gignac SM, Pettit GR, Hoffbrand AV. Eur J Immunol; 1990 Jan; 20(1):119-27. PubMed ID: 1689659 [Abstract] [Full Text] [Related]
4. Expression of proto-oncogene c-jun during differentiation of B-chronic lymphocytic leukemia. Gignac SM, Buschie M, Pettit GR, Hoffbrand AV, Drexler HG. Leukemia; 1990 Jun; 4(6):441-4. PubMed ID: 2113601 [Abstract] [Full Text] [Related]
5. Response of Jurkat T cells to phorbol ester and bryostatin. Development of sublines with distinct functional responses and changes in protein kinase C activity. Levine BL, May WS, Tyler PG, Hess AD. J Immunol; 1991 Nov 15; 147(10):3474-81. PubMed ID: 1834742 [Abstract] [Full Text] [Related]
6. Effects of bryostatins 1 and 2 on morphological and functional differentiation of SH-SY5Y human neuroblastoma cells. Jalava AM, Heikkilä J, Akerlind G, Pettit GR, Akerman KE. Cancer Res; 1990 Jun 01; 50(11):3422-8. PubMed ID: 2334938 [Abstract] [Full Text] [Related]
7. Modulation of protein kinase C activity and calcium-sensitive isoform expression in human myeloid leukemia cells by bryostatin 1: relationship to differentiation and ara-C-induced apoptosis. Grant S, Turner AJ, Freemerman AJ, Wang Z, Kramer L, Jarvis WD. Exp Cell Res; 1996 Oct 10; 228(1):65-75. PubMed ID: 8892972 [Abstract] [Full Text] [Related]
8. Human interleukin 4 down-regulates the surface expression of CD5 on normal and leukemic B cells. Defrance T, Vanbervliet B, Durand I, Banchereau J. Eur J Immunol; 1989 Feb 10; 19(2):293-9. PubMed ID: 2467815 [Abstract] [Full Text] [Related]
9. Evidence of a functional role for the cyclin-dependent kinase inhibitor p21(WAF1/CIP1/MDA6) in the reciprocal regulation of PKC activator-induced apoptosis and differentation in human myelomonocytic leukemia cells. Wang Z, Su ZZ, Fisher PB, Wang S, VanTuyle G, Grant S. Exp Cell Res; 1998 Oct 10; 244(1):105-16. PubMed ID: 9770354 [Abstract] [Full Text] [Related]
10. Expression of CD5 and CD38 by human CD5- B cells: requirement for special stimuli. Zupo S, Dono M, Massara R, Taborelli G, Chiorazzi N, Ferrarini M. Eur J Immunol; 1994 Jun 10; 24(6):1426-33. PubMed ID: 7515814 [Abstract] [Full Text] [Related]
11. Cellular activation without proliferation to B cell growth factor and interleukin 2 in chronic lymphocytic leukaemia B cells stimulated with phorbol ester plus calcium ionophore. Engel P, Inglés J, de la Calle O, Gallart T. Clin Exp Immunol; 1989 Apr 10; 76(1):61-7. PubMed ID: 2500274 [Abstract] [Full Text] [Related]
12. Bryostatin 1 induces differentiation of B-chronic lymphocytic leukemia cells. Drexler HG, Gignac SM, Jones RA, Scott CS, Pettit GR, Hoffbrand AV. Blood; 1989 Oct 10; 74(5):1747-57. PubMed ID: 2506950 [Abstract] [Full Text] [Related]
13. Protein kinase inhibitor, staurosporine, induces a mature neuronal phenotype in SH-SY5Y human neuroblastoma cells through an alpha-, beta-, and zeta-protein kinase C-independent pathway. Jalava A, Akerman K, Heikkilä J. J Cell Physiol; 1993 May 10; 155(2):301-12. PubMed ID: 8482723 [Abstract] [Full Text] [Related]
14. Differences in constitutive and activation-induced expression of CD69 and CD95 between normal and chronic lymphocytic leukemia B cells. De Fanis U, Romano C, Dalla Mora L, Sellitto A, Guastafierro S, Tirelli A, Bresciano E, Giunta R, Lucivero G. Oncol Rep; 2003 May 10; 10(3):653-8. PubMed ID: 12684639 [Abstract] [Full Text] [Related]
15. Sequential treatment of a resistant chronic lymphocytic leukemia patient with bryostatin 1 followed by 2-chlorodeoxyadenosine: case report. Ahmad I, Al-Katib AM, Beck FW, Mohammad RM. Clin Cancer Res; 2000 Apr 10; 6(4):1328-32. PubMed ID: 10778958 [Abstract] [Full Text] [Related]
16. Transcriptional regulation of CD6 expression on human T lymphocytes by phorbol ester. Bott CM, Doshi JB, Li LL, McMurtry SA, Sanders JL, Fox DA. J Immunol; 1994 Jul 01; 153(1):1-9. PubMed ID: 8207228 [Abstract] [Full Text] [Related]
17. Sequential treatment of human chronic lymphocytic leukemia with bryostatin 1 followed by 2-chlorodeoxyadenosine: preclinical studies. Mohammad RM, Katato K, Almatchy VP, Wall N, Liu KZ, Schultz CP, Mantsch HH, Varterasian M, al-Katib AM. Clin Cancer Res; 1998 Feb 01; 4(2):445-53. PubMed ID: 9516935 [Abstract] [Full Text] [Related]
18. Expression and regulation of CD5 on in vitro activated human B cells. Freedman AS, Freeman G, Whitman J, Segil J, Daley J, Levine H, Nadler LM. Eur J Immunol; 1989 May 01; 19(5):849-55. PubMed ID: 2472277 [Abstract] [Full Text] [Related]
19. Modulation of gene expression in the acute promyelocytic leukemia cell line NB4. Hu ZB, Ma W, Uphoff CC, Lanotte M, Drexler HG. Leukemia; 1993 Nov 01; 7(11):1817-23. PubMed ID: 7901456 [Abstract] [Full Text] [Related]
20. Inhibition of phorbol ester-induced T cell proliferation by bryostatin is associated with rapid degradation of protein kinase C. Isakov N, Galron D, Mustelin T, Pettit GR, Altman A. J Immunol; 1993 Feb 15; 150(4):1195-204. PubMed ID: 8432975 [Abstract] [Full Text] [Related] Page: [Next] [New Search]